Peregrine Capital Management’s Athenahealth, Inc. ATHN Stock Holding History

Peregrine Capital Management’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-89,656	Closed	-$11.8M	–	340
2018 Q4	$11.8M	Sell	89,656 -44,711	-33%	-$5.73M	0.33%	130
2018 Q3	$18M	Buy	134,367 +3,534	+3%	+$529K	0.43%	107
2018 Q2	$20.8M	Sell	130,833 -6,920	-5%	-$1.03M	0.52%	72
2018 Q1	$19.7M	Sell	137,753 -6,689	-5%	-$914K	0.48%	77
2017 Q4	$19.2M	Buy	144,442 +904	+0.6%	+$116K	0.45%	82
2017 Q3	$17.9M	Buy	143,538 +4,877	+4%	+$672K	0.43%	91
2017 Q2	$19.5M	Sell	138,661 -35,179	-20%	-$4.39M	0.49%	73
2017 Q1	$19.3M	Buy	+173,840	New	+$20.3M	0.49%	70

Peregrine Capital Management's ATHN Position: Q1 2019 in Review

Peregrine Capital Management sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 89,656 shares — an estimated $11.8M sold.

Peregrine Capital Management first reported a position in ATHN in Q1 2017 and held it in 8 quarters. The position peaked at $20.8M in Q2 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

Peregrine Capital Management reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
Peregrine Capital Management sold 89,656 Athenahealth, Inc. shares in Q1 2019, an estimated $11.8M.
Peregrine Capital Management first reported a position in Athenahealth, Inc. in Q1 2017 and held it in 8 quarters.
Peregrine Capital Management's Athenahealth, Inc. position peaked at $20.8M in Q2 2018.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Peregrine Capital Management's 13F filing for Q1 2019, filed 12 Apr 2019.